Snider Financial Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $9.56M | Buy |
12,266
+450
| +4% | +$351K | 2.76% | 7 |
|
2025
Q1 | $9.76M | Sell |
11,816
-62
| -0.5% | -$51.2K | 3.17% | 7 |
|
2024
Q4 | $9.17M | Buy |
11,878
+184
| +2% | +$142K | 2.84% | 9 |
|
2024
Q3 | $10.4M | Sell |
11,694
-195
| -2% | -$173K | 3.79% | 5 |
|
2024
Q2 | $10.8M | Buy |
11,889
+14
| +0.1% | +$12.7K | 4.16% | 4 |
|
2024
Q1 | $9.24M | Buy |
11,875
+674
| +6% | +$524K | 3.85% | 4 |
|
2023
Q4 | $6.53M | Sell |
11,201
-155
| -1% | -$90.4K | 3.01% | 10 |
|
2023
Q3 | $6.1M | Buy |
11,356
+810
| +8% | +$435K | 2.95% | 12 |
|
2023
Q2 | $4.95M | Buy |
10,546
+1,887
| +22% | +$885K | 2.37% | 11 |
|
2023
Q1 | $2.97M | Hold |
8,659
| – | – | 1.59% | 25 |
|
2022
Q4 | $3.17M | Buy |
+8,659
| New | +$3.17M | 1.75% | 19 |
|